Dose Ranging Study to Evaluate the Safety and Tolerability of SCX-001 Cream in Healthy Volunteers With Induced Dermal Incisions

计划入组 24 人 · 首次发布于 2017 年 1 月 30 日

Cyberdyne HAL, TecnoBody D-Wall, and Walker View 3.0 SCX Combined Treatment

计划入组 1 人 · 首次发布于 2024 年 7 月 24 日

SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

计划入组 2 人 · 首次发布于 2013 年 12 月 17 日

Nefopam Hydrochloride

Rovalpituzumab tesirine

STX

CEL-SCI

United States

Grupo Unamis Scp

Mexico

SGX Pharmaceuticals, Inc.

United States

MSCs Show Promise for Rotator Cuff Repair Through Immune Modulation and Tissue Engineering

EMA's CHMP Recommends Approval of Six New Biosimilars

Duchenne Muscular Dystrophy: Biotech Firms Advance Novel Therapies